Peo in Interest of Wolfe

CourtColorado Court of Appeals
DecidedMay 21, 2026
Docket26CA0267
StatusUnpublished

This text of Peo in Interest of Wolfe (Peo in Interest of Wolfe) is published on Counsel Stack Legal Research, covering Colorado Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Peo in Interest of Wolfe, (Colo. Ct. App. 2026).

Opinion

26CA0267 Peo in Interest of Wolfe 05-21-2026

COLORADO COURT OF APPEALS

Court of Appeals No. 26CA0267 Pueblo County District Court No. 25MH30072 Honorable Amiel Markenson, Judge

The People of the State of Colorado,

Petitioner-Appellee,

In the Interest of Elliot Wolfe,

Respondent-Appellant.

ORDER AFFIRMED

Division A Opinion by JUDGE TAUBMAN* C.J. Román, and Martinez*, J., concur

NOT PUBLISHED PURSUANT TO C.A.R. 35(e) Announced May 21, 2026

Cynthia Mitchell, County Attorney, Kate H. Shafer, Special Assistant County Attorney, Pueblo, Colorado, for Petitioner-Appellee

Tezak Law, P.C., Mary Tezak, Florence, Colorado, for Respondent-Appellant

*Sitting by assignment of the Chief Justice under provisions of Colo. Const. art. VI, § 5(3), and § 24-51-1105, C.R.S. 2025. ¶1 Elliot Wolfe appeals the district court’s order authorizing staff

at the Colorado Mental Health Hospital in Pueblo (the hospital) to

medicate him without his consent. We affirm.

I. Background

¶2 Wolfe was admitted to the hospital in July 2025 after being

found incompetent to proceed in two criminal cases. His symptoms

included pressured speech, agitation, moodiness, disorganized

thinking, and making delusional statements. Wolfe was started on

emergency medications after he began screaming and making

threatening statements to, and physically posturing at, staff

members. He was diagnosed with an unspecified mood disorder.

¶3 In August 2025, the district court granted the People’s petition

for authorization to involuntarily medicate Wolfe with Zyprexa

(olanzapine) and Thorazine (chlorpromazine), both antipsychotic

medications; as well as Depakote (valproic acid), a mood-stabilizing

medication. On appeal, a division of this court affirmed. See People

v. Wolfe, (Colo. App. No. 25CA1501, Nov. 13, 2025) (not published

pursuant to C.A.R. 35(e)).

1 ¶4 In January 2026, the People again petitioned the district court

for authorization to involuntarily medicate Wolfe, this time

requesting only Zyprexa and Depakote.

¶5 At the hearing on the petition, Wolfe’s psychiatrist at the

hospital, Dr. Paul Mattox, and Wolfe both testified. Dr. Mattox

testified that Wolfe’s unspecified mood disorder, which Dr. Mattox

described as “severe,” constituted a substantial disorder that

impaired Wolfe’s judgment or capacity to recognize reality or control

his behavior. While discussing Wolfe’s symptoms, Dr. Mattox

described two of Wolfe’s delusional beliefs: that his national birth

certificate was being destroyed and that his public defender was a

Jehovah’s Witness. Dr. Mattox described that Wolfe’s condition had

improved on the medications, and opined that, without the

medications, Wolfe would experience a significant, likely long-term

deterioration of his mental condition. He also testified that Wolfe

had been experiencing hand tremors, which could be caused by

Depakote, but that he could take propranolol to decrease the

tremors.

¶6 Wolfe testified that he did not believe that he had a mental

illness and did not need medication, explaining that “[t]heir

2 medications only screw things up.” But he also testified that he

was willing to take Zyprexa and Depakote voluntarily “if [he] feel[s]

it’s necessary,” explaining that he is “old enough and know[s]

enough to know when [he] need[s] to take medication and when [he

doesn’t].” He clarified that Zyprexa was not causing him any side

effects, but that he preferred a different medication than Depakote

because of his hand tremors.

¶7 Following the testimony, the district court found that Dr.

Mattox had testified credibly and persuasively, and it adopted Dr.

Mattox’s opinions. The court also specifically found that Wolfe’s

testimony that he would take the medications voluntarily if they

weren’t court-ordered was not credible. The court then examined

each of the four elements of the test from People v. Medina, 705

P.2d 961, 973 (Colo. 1985), concluded that the People had met their

burden of proving all four elements, and granted the petition.

II. Applicable Law and Standard of Review

¶8 The parties agree that the Medina test applies here. Under

that test, a district court may authorize the involuntary

administration of antipsychotic medication if the People

demonstrate by clear and convincing evidence that

3 (1) the patient is incompetent to effectively participate in the

treatment decision;

(2) the treatment with antipsychotic medication is necessary to

prevent a significant and likely long-term deterioration in the

patient’s mental health condition or to prevent the likelihood

of the patient causing serious harm to himself, herself, or

others in the institution;

(3) a less intrusive treatment alternative is not available; and

(4) the patient’s need for treatment with antipsychotic

medication is sufficiently compelling to override any bona fide

and legitimate interest the patient has in refusing treatment.1

¶9 Application of the Medina test involves mixed questions of fact

and law. People v. Marquardt, 2016 CO 4, ¶ 8, 364 P.3d 499, 502.

We defer to the district court’s factual findings if they have record

1 A different test applies to petitions to administer medication

involuntarily for the purpose of restoring a defendant’s competency in a criminal case. See People in Interest of R.F., 2019 COA 110, ¶¶ 10-15 & n.1 (discussing the test from Sell v. United States, 539 U.S. 166, 180 (2003)). Although Wolfe was initially admitted to the hospital for that purpose, the petition’s stated purpose, and the district court’s basis for granting the petition, was to prevent a significant and long-term deterioration in his mental condition. This consideration is relevant to the second Medina element. See id. at ¶ 11 n.1.

4 support, while we review the court’s legal conclusions de novo. Id.

Resolving conflicts in testimony and determining the credibility of

the witnesses are matters solely within the province of the district

court. People in Interest of Ramsey, 2023 COA 95, ¶ 23, 541 P.3d

1198, 1204.

III. Analysis

¶ 10 Wolfe does not contest the district court’s ruling that the

People met their burden of proving the first and third Medina

elements. However, he challenges the sufficiency of the evidence

supporting the court’s rulings that the People met their burden of

proving the second and fourth Medina elements.

¶ 11 On a sufficiency challenge, we must determine whether the

evidence, viewed as a whole and in the light most favorable to the

People, is sufficient to support the district court’s order. People in

Interest of R.K.L., 2016 COA 84, ¶ 13, 412 P.3d 827, 832. The

testimony of the physician seeking to administer treatment may be

sufficient, without more, to satisfy the Medina test. Id. at ¶ 30, 412

P.3d at 834.

5 A. The Second Medina Element

¶ 12 The district court found that the medications were necessary

to prevent a significant and likely long-term deterioration in Wolfe’s

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sell v. United States
539 U.S. 166 (Supreme Court, 2003)
People v. Medina
705 P.2d 961 (Supreme Court of Colorado, 1985)
People v. Marquardt
2016 CO 4 (Supreme Court of Colorado, 2016)
People ex rel. R.K.L
2016 COA 84 (Colorado Court of Appeals, 2016)
in Interest of R.F
2019 COA 110 (Colorado Court of Appeals, 2019)
People ex rel. R.K.L.
412 P.3d 827 (Colorado Court of Appeals, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Peo in Interest of Wolfe, Counsel Stack Legal Research, https://law.counselstack.com/opinion/peo-in-interest-of-wolfe-coloctapp-2026.